Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -278 | -181 | -85 | -30 | -231 |
| Depreciation Amortization | 23 | 15 | 8 | 31 | 24 |
| Accounts receivable | -19 | 174 | -140 | 463 | 574 |
| Accounts payable and accrued liabilities | 306 | 4 | -85 | -490 | -530 |
| Other Working Capital | 175 | 109 | -251 | 97 | -84 |
| Other Operating Activity | -272 | -164 | 227 | 46 | -30 |
| Operating Cash Flow | $-65 | $-43 | $-325 | $117 | $-277 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -9 | -2 | -32 | -21 |
| Other Investing Activity | 1 | 1 | 1 | 6 | 5 |
| Investing Cash Flow | $-10 | $-8 | $-2 | $-26 | $-16 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,450 | 2,450 | 2,450 | 2,360 | 2,360 |
| End Cash Position | 2,375 | 2,399 | 2,123 | 2,450 | 2,067 |
| Net Cash Flow | $-75 | $-51 | $-327 | $91 | $-293 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65 | -43 | -325 | 117 | -277 |
| Capital Expenditure | -11 | -9 | -2 | -32 | -21 |
| Free Cash Flow | -76 | -52 | -328 | 85 | -298 |